Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

FZMD US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Fuse Medical, Inc.(FZMD US)

$0.03+0.000.00%(Market Open · 21:00:00 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

FZMD US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Fuse Medical, Inc.(FZMD US)

$0.03+0.000.00%(Market Open · 21:00:00 UTC)
Ask AI
Doc SearchProfileEntity StructureFinancialsChartingShort InterestEmployees

Overview

ProfileEntity Structure

Documents

SEC Filings

Financials & Metrics

FinancialsChartingShort InterestEmployees

Financials & Metrics

FinancialsChartingShort InterestEmployees

Fuse Medical, Inc. — Company Profile

Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UU
CEO
Christopher C. Reeg
Headquarters
Farmers Branch, TX, US
IPO Date
May 6, 1999
Employees
31
Website
www.fusemedical.com

Key Metrics

Price
$0.03
Market Cap
$2.44M
Revenue (TTM)
$10.73M
Net Income (TTM)
$513.96K
EPS (TTM)
0.01
P/E (TTM)
0.67
P/B (TTM)
0.37
Dividend Yield
250.10%
ROE (TTM)
7.79%
ROA (TTM)
3.54%
Operating Margin
6.73%
Beta
1.20

Dividends

Last Dividend
$0.50
Last Yield
2.50%

Summary

Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.

Website
www.fusemedical.com
Location
Farmers Branch, TX, US
Phone469 862 3030
Employees31
CEOChristopher C. Reeg
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateMay 6, 1999

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(382)

Expand
  • 15-12GNotice of suspension of duty to file27 Sep 2023
  • 8-KResults of Operations and Financial Condition27 Sep 2023
  • 8-KResults of Operations and Financial Condition15 Aug 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023
  • 8-KSubmission of Matters to Shareholder Vote26 Jun 2023
  • 10-QQ1ended 31 Mar 202315 May 2023
  • DEFA14ADefinitive additional materials10 May 2023
  • ARSAnnual report to security holders10 May 2023
  • DEF 14ADefinitive proxy statement10 May 2023
  • 8-KFOR IMMEDIATE RELEASE18 Apr 2023
  • 10-KFY 2022ended 31 Dec 202214 Apr 2023
  • NT 10-KFY 2022ended 31 Dec 20223 Apr 2023
  • Form 4Brooks Mark W16 Dec 2022
  • Form 4Reeg Christopher C16 Dec 2022
  • Form 4Yellin Lawrence Scott16 Dec 2022
  • 8-KChange in Certifying Accountant22 Nov 2022
  • 8-KSeptember 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,49218 Nov 2022
  • Form 4Brooks Mark W17 Nov 2022
  • 10-QQ3ended 30 Sept 202214 Nov 2022
  • 10-QQ2ended 30 Jun 202211 Aug 2022

News

  • Golf Rounds.com (OTCMKTS:FZMD) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why25 Sep

Key Stats

Trading

Px/Chg 1D$0.03 / +65.00%
Avg Volume36.93K
Beta1.20
Mkt Cap2.44M
FD Mkt Cap1.48M

Float

Shrs Out/Float73.90M / 10.57M
Short Float0.00%
Days to Cover999.99
Stock Repurchased$0.00

Current Valuation

EV4.45M
EV/EBITDA1.12
EV/Sales0.24
P/B0.37
P/S0.13
FCF Yield-8.99%
ROE7.79%
ROA3.54%
Current Ratio1.42

Dividend

Cash$0.50
Yield250.10%
Yield (TTM)250.10%

Estimates

P/E0.67
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgMay '21May '22May '23Dec '24Oct '26
PRICE-BASED RATIOS
Price / Earnings-0.83-5.39-10.190.915.784.74
Price / Sales0.410.360.790.150.520.23
Price / Book Value-1.94-3.66-4.71-9.057.340.37
Price / Free Cash Flow19.2835.78-9.1080.830.00-11.12
ENTERPRISE VALUE METRICS
Enterprise Value9.38.318.45.010.24.5
Enterprise Value / Sales0.520.390.900.270.630.42
Enterprise Value / EBITDA-1.54-6.85-12.921.465.565.05
Enterprise Value / EBIT-0.99-6.30-12.331.525.986.17

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue-15.9%21.420.418.616.110.7
Gross Income-14.3%12.711.911.510.76.9
EBITDA—-1.2-1.43.41.80.9
EBIT—-1.3-1.53.31.70.7
Net Income—-1.4-1.63.11.50.5
EPS (Diluted)—-0.02-0.020.040.020.01
BALANCE SHEET
Cash & ST Inv-35.9%1.20.60.10.20.2
Total Assets-4.5%17.418.319.816.314.5
Total Liabilities-20.2%19.521.720.115.17.9
Total Shareholder Equity—-2.1-3.4-0.31.16.6
CASH FLOW
Net Operating Cash Flow—0.2-1.80.00.4-0.1
Cap Ex35.9%-0.0---0.4-0.1
Free Cash Flow—0.2-1.80.0--0.2

Enterprise Value Bridge

Millions USD10 Nov '26
Price (As of 10 Nov '26)0.03
Basic Shares73.90
Market Cap2.2
Diluted Shares77.86
Fully Diluted Shares Outstanding77.86
Fully Diluted Market Cap2.3
+Consolidated Debt2.2
−In-the-Money Convertible Debt—
+Capital Leases0.0
+Operating Leases—
−Cash & Equivalents-0.2
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value4.2

Related companies

Henry Schein Inc

HSIC US

Accendra Health Inc/va/

ACH US

Neighpart International Corp.

NIDV US

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG

Fuse Medical, Inc. — Company Profile

Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.

Sector
Health Care
Industry
Health Care Equipment & Supplies
Exchange
UU
CEO
Christopher C. Reeg
Headquarters
Farmers Branch, TX, US
IPO Date
May 6, 1999
Employees
31
Website
www.fusemedical.com

Key Metrics

Price
$0.03
Market Cap
$2.44M
Revenue (TTM)
$10.73M
Net Income (TTM)
$513.96K
EPS (TTM)
0.01
P/E (TTM)
0.67
P/B (TTM)
0.37
Dividend Yield
250.10%
ROE (TTM)
7.79%
ROA (TTM)
3.54%
Operating Margin
6.73%
Beta
1.20

Dividends

Last Dividend
$0.50
Last Yield
2.50%

Summary

Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U.S.-based manufacturer and supplier of medical device implants. Its product portfolio primarily encompasses a wide range of orthopedic implants. This includes specialized internal and external fixation devices for the foot and ankle, as well as plating systems and total joint reconstruction implants designed for upper and lower extremities. Additionally, Fuse Medical provides solutions for soft tissue fixation and augmentation, catering to sports medicine procedures. The company's offerings extend to comprehensive spinal implants, addressing indications such as trauma, degenerative disc disease, and various deformities. Beyond its orthopedic line, the company also supplies osteo-biologics and regenerative products. These encompass a variety of materials such as human allografts, tendons, synthetic skin, bone substitutes, and other regenerative tissues. Fuse Medical's client base includes hospitals, diverse medical facilities, and a network of sub-distributors.

Website
www.fusemedical.com
Location
Farmers Branch, TX, US
Phone469 862 3030
Employees31
CEOChristopher C. Reeg
Sector
Health Care
Industry
Health Care Equipment & Supplies
IPO DateMay 6, 1999

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

SEC Filings(382)

Expand
  • 15-12GNotice of suspension of duty to file27 Sep 2023
  • 8-KResults of Operations and Financial Condition27 Sep 2023
  • 8-KResults of Operations and Financial Condition15 Aug 2023
  • 10-QQ2ended 30 Jun 202314 Aug 2023
  • 8-KSubmission of Matters to Shareholder Vote26 Jun 2023
  • 10-QQ1ended 31 Mar 202315 May 2023
  • DEFA14ADefinitive additional materials10 May 2023
  • ARSAnnual report to security holders10 May 2023
  • DEF 14ADefinitive proxy statement10 May 2023
  • 8-KFOR IMMEDIATE RELEASE18 Apr 2023
  • 10-KFY 2022ended 31 Dec 202214 Apr 2023
  • NT 10-KFY 2022ended 31 Dec 20223 Apr 2023
  • Form 4Brooks Mark W16 Dec 2022
  • Form 4Reeg Christopher C16 Dec 2022
  • Form 4Yellin Lawrence Scott16 Dec 2022
  • 8-KChange in Certifying Accountant22 Nov 2022
  • 8-KSeptember 30,2022December 31,2021(Unaudited)AssetsCurrent assets:Cash$505,989$553,190Accounts receivable, net of allowance of $392,135 and $498,261, respectively2,625,9493,528,992Inventories9,850,6828,736,474Prepaid expenses and other current assets33,7125,921Total current assets13,016,33212,824,577Property and equipment, net399,9487,251Long term accounts receivable, net of allowance of $3,937,568 and $3,355,391, respectively2,570,5542,182,437Intangible assets, net1,223,6951,317,341Goodwill1,972,8861,972,886Total assets$19,183,415$18,304,492Liabilities and Stockholders' Equity (Accumulated Deficit)Current liabilities:Accounts payable$4,822,278$4,461,641Accrued expenses4,244,4002,898,068Convertible notes payable - related parties150,000150,000Notes payable - related parties200,000200,000Senior secured revolving credit facility2,044,6062,432,770Total current liabilities11,461,28410,142,479Earn-out liability11,593,83211,593,832Total liabilities23,055,11621,736,311Commitments and contingencies--Stockholders' equity (accumulated deficit)Preferred stock, $0.01 par value; 20,000,000 shares authorized, no shares issued andoutstanding--Common stock, $0.01 par value; 100,000,000 shares authorized, 72,895,793 shares issued and outstanding as of June 30, 2022 and December 31, 2021.728,958728,958Additional paid-in capital1,476,5161,455,422Accumulated deficit(6,077,175)(5,616,199)Total stockholders' equity (accumulated deficit)(3,871,701)(3,431,819)Total liabilities and stockholders' equity (accumulated deficit)$19,183,415$18,304,49218 Nov 2022
  • Form 4Brooks Mark W17 Nov 2022
  • 10-QQ3ended 30 Sept 202214 Nov 2022
  • 10-QQ2ended 30 Jun 202211 Aug 2022

News

  • Golf Rounds.com (OTCMKTS:FZMD) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why25 Sep

Key Stats

Trading

Px/Chg 1D$0.03 / +65.00%
Avg Volume36.93K
Beta1.20
Mkt Cap2.44M
FD Mkt Cap1.48M

Float

Shrs Out/Float73.90M / 10.57M
Short Float0.00%
Days to Cover999.99
Stock Repurchased$0.00

Current Valuation

EV4.45M
EV/EBITDA1.12
EV/Sales0.24
P/B0.37
P/S0.13
FCF Yield-8.99%
ROE7.79%
ROA3.54%
Current Ratio1.42

Dividend

Cash$0.50
Yield250.10%
Yield (TTM)250.10%

Estimates

P/E0.67
Est P/E0.00
Est EPS0.00
Est PEG0.00

Valuation

Metric5Yr AvgMay '21May '22May '23Dec '24Oct '26
PRICE-BASED RATIOS
Price / Earnings-0.83-5.39-10.190.915.784.74
Price / Sales0.410.360.790.150.520.23
Price / Book Value-1.94-3.66-4.71-9.057.340.37
Price / Free Cash Flow19.2835.78-9.1080.830.00-11.12
ENTERPRISE VALUE METRICS
Enterprise Value9.38.318.45.010.24.5
Enterprise Value / Sales0.520.390.900.270.630.42
Enterprise Value / EBITDA-1.54-6.85-12.921.465.565.05
Enterprise Value / EBIT-0.99-6.30-12.331.525.986.17

Financials

Full Financials
Millions USD5Yr CAGR (%)Dec '20Dec '21Dec '22Dec '23Dec '24
INCOME STATEMENT
Revenue-15.9%21.420.418.616.110.7
Gross Income-14.3%12.711.911.510.76.9
EBITDA—-1.2-1.43.41.80.9
EBIT—-1.3-1.53.31.70.7
Net Income—-1.4-1.63.11.50.5
EPS (Diluted)—-0.02-0.020.040.020.01
BALANCE SHEET
Cash & ST Inv-35.9%1.20.60.10.20.2
Total Assets-4.5%17.418.319.816.314.5
Total Liabilities-20.2%19.521.720.115.17.9
Total Shareholder Equity—-2.1-3.4-0.31.16.6
CASH FLOW
Net Operating Cash Flow—0.2-1.80.00.4-0.1
Cap Ex35.9%-0.0---0.4-0.1
Free Cash Flow—0.2-1.80.0--0.2

Enterprise Value Bridge

Millions USD10 Nov '26
Price (As of 10 Nov '26)0.03
Basic Shares73.90
Market Cap2.2
Diluted Shares77.86
Fully Diluted Shares Outstanding77.86
Fully Diluted Market Cap2.3
+Consolidated Debt2.2
−In-the-Money Convertible Debt—
+Capital Leases0.0
+Operating Leases—
−Cash & Equivalents-0.2
−Short-term Investments-
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value4.2

Related companies

Henry Schein Inc

HSIC US

Accendra Health Inc/va/

ACH US

Neighpart International Corp.

NIDV US

WuXi AppTec Co., Ltd.

WUXAY US

Natera, Inc.

NTRA US

Labcorp Holdings Inc.

LH US

Guardant Health, Inc.

GH US

WuXi XDC Cayman Inc

2268 HK

Caris Life Sciences, Inc.

CAI US

Sonic Healthcare Ltd / ADR

SKHHY US

GRAIL, Inc.

GRAL US

Joinn Laboratories(China)Co.,Ltd.

603127 CG